-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632.O2.6 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Longer Term Response, TFR, Pregnancy, and Disparities

Symposia: Chronic Myeloid Leukemia: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, adult, Biological therapies, Non-Biological therapies, Clinical Practice (Health Services and Quality), Clinical Research, CML, Chemotherapy, embryo/fetus, health disparities research, Diversity, Equity, and Inclusion (DEI) , Chronic Myeloid Malignancies, Diseases, patient-reported outcomes, neonatal, Therapies, pregnant, Immunotherapy, therapy sequence, Adverse Events, Myeloid Malignancies, Study Population, Human, Minimal Residual Disease , Maternal Health
Sunday, December 11, 2022: 4:30 PM-6:00 PM
388-390 (Ernest N. Morial Convention Center)
Moderators:
Jorge Cortes, MD, Georgia Cancer Center Augusta University and Carmen Fava, MD, PhD, ARRAY(0xf5d79a0)
Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Georgina Gener-Ricos1*, Fadi Haddad, MD1*, Koji Sasaki, MD1, Ghayas C. Issa, MD2, Jeffrey Skinner, MHA1*, Koichi Takahashi, MD, PhD3, Lucia Masarova, MD1, Jan A. Burger, MD, PhD1, Gautam Borthakur, MD1, Prithviraj Bose, MD4, Guillermo Garcia-Manero, MD5, Elias Jabbour, MD1 and Hagop Kantarjian, MD6

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, Universit Y of Texas At Houston, Houston, TX
3Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

4:45 PM

Jorge E. Cortes, MD1, Michael W. Deininger, MD, PhD2, Elza Lomaia, MD, PhD3*, Beatriz Moiraghi, MD4*, Maria Undurraga Sutton5*, Carolina Pavlovsky6*, Charles Chuah, MD7*, Tomasz Sacha, MD, PhD8*, Jeffrey H. Lipton, MD, PhD9, James McCloskey, MD10*, Andreas Hochhaus11, Philippe Rousselot, MD, PhD12*, Gianantonio Rosti13*, Hugues de Lavallade, MD14*, Christine Rojas, MD15*, Anna Turkina, MD16*, Lori Maness, MD17, Moshe Talpaz, MD18, Michael Mauro, MD19, Vickie Lu, PhD20*, Alexander Vorog, MD20* and Jane F. Apperley, FRCP, FRCPath, MB21

1Georgia Cancer Center, Augusta, GA
2Versiti Blood Research Institute, Milwaukee, WI
3Almazov National Medical Research Centre, St. Petersburg, Russian Federation
4Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina
5Hospital del Salvador, Santiago, Chile
6Fundaleu, Buenos Aires, Argentina
7Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore
8Jagiellonian University Hospital, Kraków, Poland
9Princess Margaret Cancer Centre, Toronto, ON, Canada
10John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
11Universitätsklinikum Jena, Jena, Germany
12Centre Hospitalier de Versailles University de Versailles Saint-Quentin-en-Yvelines, Paris, France
13IRST/IRCCS “Dino Amadori,”, Meldola (FC), Ravenna, Italy
14King's College Hospital NHS Foundation, London, United Kingdom
15Centro de Investigaciones Clinicas Vina del Mar, Valparaíso, Chile
16National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russian Federation
17University of Nebraska Medical Center, Omaha, NE
18Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
19Memorial Sloan Kettering, New York, NY
20Takeda Development Center Americas, Inc., Lexington, MA
21Imperial College London, London, United Kingdom

5:00 PM

Ekaterina Yu. Chelysheva, MD, PhD1*, Anna Turkina, MD2*, Jane F. Apperley, FRCP, FRCPath, MB3, Mohamed A Yassin, MBBS, MSC, CABM, MSC, FACP4, Delphine Rea, MD, PhD5, Franck E. Nicolini, MD, PhD6, Daniela Barraco7*, Konstantin Kotlyarchuk8*, Khamida Kazakbaeva, MD9*, Sukhrob Saliev9*, Adi Shacham, MD10*, Dong-Wook Kim, M.D., Ph.D.11, Salam Al-Kindi, MD12*, Penka Ganeva13*, Roman Shmakov, MD, PhD14*, Jennifer Byrne, PhD, FRCPath15*, Harry Robertson16*, Cerrano Marco, MD17*, Evgenia Polushkina14*, Malgorzata Monika Trawinska, MD18* and Elisabetta Abruzzese, MD19

1National Medical Research Center for Hematology, Moscow, AZ
2National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russian Federation
3Centre for Haematology, Imperial College London at the Hammersmith Hospital, London, ENG, United Kingdom
4Department of Medical Oncology/ Hematology Section, National Centre For Cancer Care & Research, Doha, Qatar
5Université de Paris, Hematology department, Saint-Louis hospital, APHP, Paris, France
6Centre Hospitalier Lyon Sud, LYON Cedex 03, France
7Local Health Authority of the Seven Lakes Hospital of Circolo, Varese, Italy
8SI 'Institute of Blood Pathology and Transfusion Medicine UAMS, Lviv, Ukraine
9Research Institute of Hematology and Blood Transfusion MOH of Uzbekistan, Tashkent, Uzbekistan
10Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
11Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
12Department of Haematology, Sultan Qaboos University, Muscat, Oman
13Department of hematology, Specilaized Hospital for Active Treatment of Hematological Diseases, Sofia, BGR
14National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation
15Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, ENG, United Kingdom
16Imperial College Healthcare NHS Trust, London, United Kingdom
17Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy
18Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy
19Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Roma, I, Italy

5:15 PM

Andreas Burchert, MD1, Susanne Saussele, MD 2, Christian Michel, MD3*, Stephan K Metzelder, MD4*, Andreas Hochhaus, MD5, Norbert Gattermann, MD6, Martina Crysandt, MD7*, Philippe Schafhausen, MD8*, Matthias Bormann, MD9*, Markus P. Radsak, MD10*, Agnès Guerci-Bresler, MD, PhD11*, Thomas Illmer, MD12, Maria E Goebeler, MD13*, Peter Herhaus, MD14*, Lino L. Teichmann, MD15*, Georg-Nikolaus Franke, MD16*, Fabian Lang, MD17*, Stefan W. Krause, MD18*, Robert Möhle, MD19, Martine Klausmann, MD20, Frank Stegelmann, MD21, Christoph Lutz, MD22*, Gabriel Etienne, MD, PhD23*, Andrea Stoltefuß, MD24*, Joachim R Göthert, MD25, Thomas Ernst, MD5, Andreas Neubauer, MD26, Rüdiger Hehlmann, MD27, Behnaz Aminossadati28*, Michael Wittenberg, PhD29*, Markus Pfirrmann, PhD30*, Carmen Schade-Brittinger31*, Philipp le Coutre, MD32 and Franck E. Nicolini, MD, PhD33

1Department of Hematology and Oncology, University Hospital Giessen and Marburg, Marburg, Germany
2III. Medizinische Klinik für Hämatologie und Onkologie, Universitätsmedizin Mannheim, Mannheim, Germany
3Department of Hematology, Oncology and Immunology, University hospital Gießen and Marburg, Marburg, Germany
4Dep. of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany
5Hematology/Oncology, Jena University Hospital, Jena, Germany
6Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany
7Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, University Hospital RWTH Aachen, Aachen, Germany
8University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
9Klinikum Bremen Mitte, Bremen, Germany
10Department of Internal Medicine III, University Medical Center, Johannes Gutenberg-University of Mainz, Mainz, Germany
11Service d'Hématologie, Centre Hospitalier Universtaire Brabois, Vandoeuvre-lès-Nancy, France
12Group Practice for Hematology and Oncology, Dresden, Germany
13Leitung CCC Trial Office, Würzburg, Germany
14Internal Medicine III, School of Medicine, Klinikum rechts der Isar, Technische Universität München, München, Germany
15Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany
16Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
17Dept. of Medicine, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany
18University Hospital Erlangen, Germany, Erlangen, Germany
19Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
20Practice for Hematology, Oncology, and Gastroenterology, Aschaffenburg, Germany
21Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
22Praxis for Hematology and Oncology, Koblenz, Germany
23Groupe Fi-LMC, Institut Bergonié, Bordeaux, France
24Evangelisches Krankenhaus Hamm, Hamm, Germany
25Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
26Klinik für Innere Medizin, Schwerpunkt Hämatologie, Onkologie und Immunologie, Philipps University, Marburg, Germany
27Universität Heidelberg and ELN-Foundation, Heidelberg, Germany
28KKS, Philipps University Marburg, Marburg, Germany
29KKS, Philipps University Marburg, Marburg, AL, DEU
30IBE, Ludwig-Maximilians-Universität, München, Germany
31KKS Marburg, Philipps University Marburg, Marburg, Germany
32Department of Hematology, Oncology and Tumor Immunology, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Berlin, Germany
33Centre Hospitalier Lyon Sud, LYON Cedex 03, France

5:30 PM

Giovanni Zambrotta1,2*, Sarit Assouline3, Franck E. Nicolini, MD, PhD4, Elisabetta Abruzzese, MD5, Maria Cristina Miggiano, MD6*, Chiara Elena, MD7*, Alberto Alvarez-Larran, MD, PhD8*, Ana Triguero8*, Alessandra Iurlo, MD, PhD9*, Cristina Bucelli, MD10*, Francesca Lunghi, MD11*, Isabella Capodanno, MD12*, Margherita Maffioli, MD13*, Sara Galimberti, MD14*, Giovanni Caocci, MD15*, Fabio Stagno, MD, PhD16, Susanne Saussele, MD 17, Carmen Fava, MD, PhD18, Philipp le Coutre, MD19, Massimiliano Bonifacio, MD20*, Veronica Guglielmana1,2*, Federica Colombo1,2*, Laura Antolini, PhD1* and Carlo Gambacorti-Passerini, MD1,2

1Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
2Hematology Division and Bone Marrow Unit, San Gerardo Hospital, Monza, Italy
3Department of Medicine and Oncology, Jewish General Hospital, McGill University, Montreal, Montreal, QC, Canada
4Hématologie clinique & INSEM U1052, Centre Léon Bérard, Lyon, France
5Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Roma, I, Italy
6Hematology Department, San Bortolo Hospital, Azienda ULSS8 "Berica" di Vicenza, Vicenza, Italy
7Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
8Hematology Department, Hospital Clínic, Barcelona, Spain
9Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
10Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
11Department of Onco-Haematology - Haematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute and Vita-Salute Hospital, Milano, Italy
12Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
13Hematology, Ospedale di Circolo e Fondazione Macchi, University of Insubria, ASST Sette Laghi, Varese, Italy
14Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Azienda ospedaliera Pisana, Pisa, Italy
15Hematology Unit, Cagliari University, Businco Hospital, Cagliari, Italy
16Division of Hematology and Bone Marrow Transplantation Unit, A.O.U. "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy
17Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
18Hematology Division, A.O. Ordine Mauriziano di Torino, Torino, Italy, Turin, Italy
19Department of Hematology, Oncology and Tumor Immunology, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Berlin, Germany
20Department of Medicine, Section of Hematology, University of Verona, Verona, Italy

5:45 PM

Catherine E. Sobieski, MD1*, Victoria A. Vardell, MD1 and Srinivas K. Tantravahi, MBBS2

1Department of Internal Medicine, University of Utah, Salt Lake City, UT
2Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

*signifies non-member of ASH